参考文献/References:
[1] GAO Chundi, ZHOU Chao, ZHUANG Jing, et al. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers[J].J CellBiochem, 2018,119(8):7080-7090.
[2] Kanyina E W, Kamau L, Muturi M. Cervicalprecancerous changes and selectedcervical microbialinfections, Kiambu County, Kenya, 2014: a crosssectionalstudy[J].BMC Infect Dis, 2017, 17(1):647.
[3] 陈慎 , 杜明君 , 宋雅琴 . 宫颈组织 HPV DNA 与血清Chemerin,Leptin 水平联合检测对宫颈癌早期诊断的价值分析 [J]. 现代检验医学杂志 , 2019, 34(3):42-46. CHEN Shen, DU Mingjun, SONG Yaqin. Value ofcombined detection of HPV DNA and serum levelsof chemerin and leptin in early diagnosis of cervicalcancer[J]．J Mod Lab Med, 2019, 34(3):42-46.
[4] TH?ODORE C, LEVAILLANT J M, CAPMAS P, etal. MRI and ultrasound fusion imaging for cervicalcancer[J].Anticancer Res, 2017, 37(9):5079-5085.
[5] ZHANG Lu , ZHOU Wei, ZHAN Weiwei. Role ofultrasound in the assessment of percutaneous laserablation of cervical metastatic lymph nodes fromthyroid carcinoma[J].Acta Radiol,2018, 59(4):434-440.
[6] 庄小捷 , 曹成莉 , 李云 , 等 . 血清 miR-130a，miR425-5p 表达水平与宫颈癌患者临床病理参数的关系及其诊断价值分析 [J]. 中国妇幼保健 , 2019, 34(9):1966-1969. ZHUANG Xiaojie, CAO Chengli, LI Yun, etal.Analysis on the relationships between serummiR-130a and miR-425-5p expression levels andclinicopathological parameters of cervical cancerpatietns and the diagnostic value[J]. Maternal & ChildHealth care of China, 2019, 34(9):1966-1969.
[7] 中国抗癌协会妇科肿瘤专业委员会 . 宫颈癌诊断与治疗指南 ( 第四版 )[J]. 中国实用妇科与产科杂志 ,2018, 34(6):613-622. Chinese Society of Gynecological Oncology. Guidelines for the diagnosis and treatment of cervical cancer(4th Edition)[J]. Chin J Pract Gynccol Obstet, 2018,34(6):613-622.
[8] GRAD?SSIMO A, BURK R D. Molecular testspotentially improving HPV screening and genotypingfor cervical cancer prevention[J].Expert Rev MolDiagn, 2017, 17(4):379-391.
[9] MUSA J, ACHENBACH C J, O’DWYER L C, etal. Effect of cervical cancer education and providerrecommendation forscreening on screening rates: Asystematic review and meta-analysis[J].PLoS One,2017, 12(9):e0183924.
[10] LI Hai, WANG Xubo, GENG Jianxiang, et al.Clinical study of styping detection of humanpapillomavirus (HPV) infection with microarray fromparaffinembedded specimens of cervical cancer andprecursor lesions[J].J Nanosci Nanotechnol, 2015,15(9):6423-6428.
[11] WANG Pingping, SUN Wenqing, WANG Longxia,et al. Correlations of p53 expressionwith transvaginalcolor Doppler ultrasound findings of cervical cancerafter radiotherapy[J].J BUON, 2018, 23(3):769-775.
[12] LIU Yingxia, LIU Yan, XU Jinmei, et al. Color Dopplerultrasound and contrast-enhanced ultrasound in thediagnosis of lacrimal apparatus tumors[J].Oncol Lett,2018, 16(2):2215-2220.
[13] ZHU Yi, ZHANG Guonan, ZHANG Ruibo, et al.Sonographic image of cervixepithelioid trophoblastictumor coexisting with mucinous a denocarcinoma inapostmenopausal woman: A case report[J].Medicine(Baltimore), 2017, 96(38):e7731.
[14] 何玉春 , 李慧敏 , 李邱静 , 等 . 经阴道彩色多普勒超声病灶内微血管与早期宫颈癌预后发展的关系 [J].实用癌症杂志 , 2017, 32(2):335-338. HE Yuchun, LI Huimin, LI Qiujing, et al. Relationshipbetween the transvaginal color doppler flow imaging( TV-CDFI) of intralesional capillaries and prognosisof early cervical cancer[J]. Practic J Cancer,2017,32(2):335-338.
[15] MASOOD N, BASHARAT Z, KHAN T, et al.Entangling relation of micro RNA-let7,miRNA-200and miRNA-125 with various cancers[J].Pathol OncolRes, 2017, 23(4):707-715.
[16] 马向薇 , 曹东华 , 仲美琦 . miR-130a 靶向调节 SMAD4基因对卵巢癌 SKOV3 细胞增殖和侵袭的影响 [J]. 解剖科学进展 , 2018, 24(2):118-121. MA Xiangwei, CAO Donghua, ZHONG Meiqi.Effects of miR-130a targeting SMAD4 gene on theproliferation and invasion of ovarian cancer SKOV3cells[J].Prog Anat Sci,2018, 24(2):118-121.
[17] 朱军 , 赵琴 . miR-425-5p 在宫颈癌中的表达及临床意义 [J]. 中国生育健康杂志 ,2017, 28(4):361-363. ZHU Jun, ZHAO Qin. Expression and clinical significance of mir-425-5p in cervical cancer[J]. Chin J Reprod Health, 2017, 28(4):361-363.
[18] WANG H R, LIN Y, ZHANG X Y, et al. Transvaginalcolor doppler sonographycombined with colposcopyfor diagnosis of early stage cervical cancer andprecancerous lesions[J].J Biol Regul Homeost Agents,2018, 32(1):123-126.
[19] PARK S, EOM K, KIM J, et al. MiR-9, miR-21, andmiR-155 as potential biomarkers for HPV positiveand negative cervical cancer[J].BMC Cancer, 2017,17(1):658.
[20] 冯磊 , 常春红 , 管晓卿 , 等 . 宫颈癌患者血浆 miRNA10b 的表达及其临床意义 [J]. 现代检验医学杂志 ,2018, 33(1):52-55,58. FENG Lei, CHANG Chunhong, GUAN Xiaoqing, etal. Expression of plasma miRNA-10b in patients withcervical cancer and its clinical significance[J]. J ModLab Med, 2018, 33(1):52-55, 58.
相似文献/References:
[1]田英,王双勇,赵雅,等.宫颈癌组织细胞中Numb基因表达及相关性研究[J].现代检验医学杂志,2015,30(06):42.[doi:10.3969/j.issn.1671-7414.2015.06.012]
TIAN Ying,WANG Shuang-yong,ZHAO Ya,et al.Study on Correlation and Expression of Numb Gene in Cervical Cancer[J].Journal of Modern Laboratory Medicine,2015,30(03):42.[doi:10.3969/j.issn.1671-7414.2015.06.012]
[2]顾益凤,朱自力,史跃燕,等.血浆硫氧还蛋白还原酶水平检测对宫颈癌早期诊断的价值研究[J].现代检验医学杂志,2019,34(02):40.[doi:10.3969/j.issn.1671-7414.2019.02.011]
GU Yi-feng,ZHU Zi-li,SHI Yue-yan,et al.Study on the Value of Plasma Thioredoxin Reductase Levelin the Early Diagnosis of Cervical Cancer[J].Journal of Modern Laboratory Medicine,2019,34(03):40.[doi:10.3969/j.issn.1671-7414.2019.02.011]
[3]陈 慎,杜明君,宋雅琴.宫颈组织HPV DNA与血清Chemerin,Leptin水平联合检测对宫颈癌早期诊断的价值分析[J].现代检验医学杂志,2019,34(03):42.[doi:10.3969/j.issn.1671-7414.2019.03.010]
CHEN Shen,DU Ming-jun,SONG Ya-qin.Value of Combined Detection of HPV DNA and Serum Levelsof Chemerin and Leptin in Early Diagnosis of Cervical Cancer[J].Journal of Modern Laboratory Medicine,2019,34(03):42.[doi:10.3969/j.issn.1671-7414.2019.03.010]
[4]周 静,李 智,周 玉,等.宫颈癌组织中 Ep-CAM和 Ki67的表达及临床意义[J].现代检验医学杂志,2019,34(06):24.[doi:10.3969 ／ j.issn.1671-7414.2019.06.006]
ZHOU Jing,LI Zhi,ZHOU Yu,et al.Expression and Clinicd Value of Ep-CAM and Ki67 in the Cervial Carcinoma Tissue[J].Journal of Modern Laboratory Medicine,2019,34(03):24.[doi:10.3969 ／ j.issn.1671-7414.2019.06.006]
[5]徐晓锋a,王 纯b,卢国丰a,等.宫颈癌患者 Kruppel 样因子 6，p21 蛋白表达水平与病理特征及化疗敏感性的相关性分析[J].现代检验医学杂志,2020,35(06):12.[doi:doi:10.3969/j.issn.1671-7414.2020.06.004]
XU Xiao-feng a,WANG Chun b,LU Guo-feng a,et al.Correlation Analysis of KLF6 and p21 Protein Expression Levels andPathological Features and Chemotherapy Sensitivity in Patientswith Cervical Cancer[J].Journal of Modern Laboratory Medicine,2020,35(03):12.[doi:doi:10.3969/j.issn.1671-7414.2020.06.004]
[6]高红敏,杨红英,刘 鑫.血清中 microRNA-106b 对宫颈癌患者的早期诊断及预后预测价值[J].现代检验医学杂志,2020,35(06):85.[doi:doi:10.3969/j.issn.1671-7414.2020.06.020]
GAO Hong-min,YANG Hong-ying,LIU Xin.Value Analysis of Serum microRNA-106b in Early Diagnosis ofCervical Cancer[J].Journal of Modern Laboratory Medicine,2020,35(03):85.[doi:doi:10.3969/j.issn.1671-7414.2020.06.020]
[7]张治洋,李功娟.10株宫颈癌细胞系中MALAT1的表达及其对顺铂敏感性的影响[J].现代检验医学杂志,2021,36(05):110.[doi:10.3969/j.issn.1671-7414.2021.05.024]
ZHANG Zhi-yang,LI Gong-juan.Expression of MALAT1 in 10 Cervical Cancer Cell Lines and Its Effect onCisplatin Sensitivity[J].Journal of Modern Laboratory Medicine,2021,36(03):110.[doi:10.3969/j.issn.1671-7414.2021.05.024]
[8]郝艳芳,刘亚荣,黄玲玲,等.miRNA-195靶向调控 CCND2和 MYB抑制宫颈癌细胞增殖、迁移的机制研究[J].现代检验医学杂志,2022,37(01):130.[doi:10.3969/j.issn.1671-7414.2022.01.026]
HAO Yan-fang,LIU Ya-rong,HUANG Ling-ling,et al.Study on the Mechanism of miRNA-195 Targeting CCND2 and MYB to Inhibit the Proliferation and Migration of Cervical Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(03):130.[doi:10.3969/j.issn.1671-7414.2022.01.026]
[9]方 芳,吴 玲,魏善闯,等.宫颈癌患者血清LCN2水平表达与HPV病毒载量及临床分期的相关研究[J].现代检验医学杂志,2022,37(02):80.[doi:10.3969/j.issn.1671-7414.2022.02.017]
FANG Fang,WU Ling,WEI Shan-chuang,et al.Correlation of Expression of Serum LCN2 Level with HPV Load and Clinical Stage in Patients with Cervical Cancer[J].Journal of Modern Laboratory Medicine,2022,37(03):80.[doi:10.3969/j.issn.1671-7414.2022.02.017]
[10]谌媛媛,李 静.宫颈脱落细胞中PAX1 和SOX1 基因甲基化对宫颈癌实验诊断的临床研究[J].现代检验医学杂志,2022,37(06):46.[doi:10.3969/j.issn.1671-7414.2022.06.009]
CHEN Yuan-yuan,LI Jing.Clinical Study of PAX1 and SOX1 Gene Methylation in Cervical Exfoliated Cells for Experimental Diagnosis of Cervical Cancer[J].Journal of Modern Laboratory Medicine,2022,37(03):46.[doi:10.3969/j.issn.1671-7414.2022.06.009]